Exploratory study of the effect of oligosaccharide intake on gut microbiota, blood marker, and physical conditio
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000053365
- Lead Sponsor
- Meiji Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Not provided
1.Those who have participated in other intervention studies in the month prior to screening or who plan to participate in other intervention studies during the period from screening to the end of the intake period 2.Those who have a history of gastric or lower gastrointestinal tract surgery excluding hemorrhoids 3.Those who have a barium stomach X-ray, small or large intestine endoscopy, or bowel cleansing at a clinic or at home in the month prior to screening or who plan to have these procedures during this study 4.Those who have taken, ingested, or used drugs that may affect the study at least once a week in the month prior to screening, or who plan to take, ingest, or use these drugs at least once during the study 5.Those who plan to travel abroad, travel for more than one week, or go on a business trip during the period from one week prior to the intake period to the end of the intake period 6.Those with lactose intolerance 7.Those with milk allergy 8.Females who are pregnant and/or lactating 9.Those judged as unsuitable for the study by the principal investigator or research physician for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method gut microbiota
- Secondary Outcome Measures
Name Time Method fecal organic acid concentration, fecal bile acid concentration, blood marker, physical conditions (height, body weight, BMI, muscle mass, body fat mass, body fat percentage, blood pressure), and incidence of adverse events